<DOC>
	<DOCNO>NCT01203124</DOCNO>
	<brief_summary>The study investigate dose AZD8848 dosing frequency affect immunological/inflammatory response measure production biomarkers blood nasal lavage .</brief_summary>
	<brief_title>A Study Investigate Impact Dose Dosing Frequency AZD8848 Response Biomarkers</brief_title>
	<detailed_description />
	<criteria>Healthy men woman age 18 55 year ( inclusive ) . Women must nonchildbearing potential must stable highly effective contraceptive method least 3 month prior Visit 1 willing continue choose contraceptive method , additional use condom male partner , 3 month last dose . Female subject negative pregnancy test Visit 2 date last menstruation consistent nonpregnancy Ability metabolise AZD8848 ( vitro screen assay determine metabolic activity blood sample take Visit 1 use predefined limit ) Any clinically significant disease disorder Any clinically relevant abnormal finding physical examination Structural abnormality nose nasal disorder symptomatic enough cause significant nasal obstruction Ongoing pregnancy lactation Abnormal immune function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Intranasal</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Healthy</keyword>
	<keyword>Effect different dos dose regimen AZD8848 biomarkers</keyword>
	<keyword>Effect different dos dose frequency AZD8848 biomarkers</keyword>
</DOC>